NDD Neurodegenerative Drug Development Europe 2019

Topics

• Seeking Robust Biomarkers of Neurodegeneration & Strategies to Improve Their Translatability
• The Future for Neurodegenerative Drug Development
• Exploring Preclinical Models of Neurodegeneration to Improve Clinical Efficacy Predictions
• Encouraging Precompetitive Strategies, Collaborations & Consortia to Advance the Neurodegenerative Field
• Assessing Therapeutic Approaches Targeting Neurodegeneration
• Assessing Current Methods of Validation of Neurodegenerative Targets
• Utilising Biomarker Strategies to Improve Patient Stratification for Clinical Trials